🧫

cGAMP biomarker analysis in ALS patient spinal cord samples

active
experiment Created: 2026-04-06T12:28:40 By: experiment_extractor Quality: 80% ✓ SciDEX ID: experiment-exp-820a16b5-8133-478d-a80d-2
🧫 Experiment Protocol Neuropathologyproposed
Related Entities
TARDBP
Metadata
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-06T12:28:40.599226'}
p_valueNone
protocolPost-mortem spinal cord tissue collection, cGAMP quantification assays, comparison between ALS patients and controls, correlation with TDP-43 pathology
effect_sizeNone
sample_sizeNone
source_pmid33031745
extracted_at2026-04-06T05:28:40.538778
_schema_version1
experiment_typeneuropathology
success_criteriaStatistically significant elevation of cGAMP levels in ALS patient samples versus controls
expected_outcomesALS patients should show significantly elevated cGAMP levels compared to controls, indicating active cGAS/STING signaling
statistical_methodsNone
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
96
Outgoing
98
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.